TandemHeart(R) PTVA(R) System From CardiacAssist Used in Nation's Top-Ranked Hospitals
Posted on: Friday, 4 August 2006, 12:00 CDT
PITTSBURGH, Aug. 4 /PRNewswire/ -- The TandemHeart(R) PTVA(R) System from CardiacAssist, the world's only extracorporeal 5.0 lpm circulatory support system, is used in 17 of the top 20 heart and heart surgery hospitals in the U.S. and 11 of the nation's top 14 hospitals overall, based on 2006 rankings recently released by U.S. News & World Report. The hospital ranking is included in the magazine's 17th annual guide to America's best hospitals.
The TandemHeart System provides circulatory support through a cardiac catheterization procedure in as little as 30 minutes and can provide up to five liters per minute (lpm) of blood flow.
"We have more than 60 hospitals across the U.S. and more than 70 worldwide that now use the TandemHeart System for extracorporeal circulatory support," said Michael Garippa, president and CEO of CardiacAssist. "It's no coincidence that so many CardiacAssist centers of excellence are among the most highly rated hospitals in the nation."
The TandemHeart System is fully reimbursed by Medicare under existing DRG codes. The device can be placed rapidly in the cath lab or operating room, providing reliable extracorporeal circulatory support.
To date, more than 650 uses of the system in 28 countries at 70 different facilities by 120 different physicians have been performed. The device has received FDA 510(k) clearance for six hour use and is the only FDA approved device of its kind in the U.S.
About CardiacAssist
Founded in 1996, CardiacAssist, Inc. is a privately held, Pittsburgh-based medical device company that develops, manufactures and markets innovative products designed to provide cardiologists and cardiac surgeons with minimally invasive solutions for providing extracorporeal circulatory support. Its vision is to help advance the treatment of heart disease by bridging gaps in current treatment methodologies.
This press release may contain certain forward-looking statements that relate to CardiacAssist's future business and financial performance. Such statements are subject to a number of risks and uncertainties that may cause the actual events or future results to differ from those discussed herein.
Media Contact: Dan Snyders Armada Medical Marketing 303-623-1190 x230 dan@armadamedical.com Monica Bush CardiacAssist, Inc. 412-963-7770 x247 mbush@cardiacassist.com
CardiacAssist, Inc.
CONTACT: Dan Snyders of Armada Medical Marketing, +1-303-623-1190 x230,or dan@armadamedical.com, for CardiacAssist, Inc.; or Monica Bush ofCardiacAssist, Inc., +1-412-963-7770 x247, or mbush@cardiacassist.com
Web site: http://www.cardiacassist.com/
Source: PRNewswire
Related Articles
- Abiomed Receives European CE Mark Approval for AB5000(R) Portable Circulatory Support Driver
- Abiomed Announces AB5000(R) Portable Circulatory Support Driver
- Abiomed Receives FDA Approval for the Combination iPulse(TM) Circulatory Support System
- Abiomed Completes Enrollment of Pilot Clinical Trial for Impella 2.5 Circulatory Support System
- Abiomed to Showcase Circulatory Support Technologies at International Society for Heart and Lung Transplantation Meeting
- CORRECTING and REPLACING SYMX Launches Comprehensive Platform for Real-Time Location System To Support Hospital Management and Quality Initiatives
- SYMX Launches Comprehensive Platform for Real-Time Location System To Support Hospital Management and Quality Initiatives
- Abiomed Announces Development of Pediatric Circulatory Support Technology
- ABIOMED Announces French Regulatory Approval of the AB5000 Circulatory Support System
- AT&T Wins Contract From Image Management Systems And Support Corp.
 |
 |
User Comments (0)
RSS Feeds